Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roger

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
European Journal of Nutrition|January 19, 2010
Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-caroteneYingming Wang, D Roger Illingworth, Sonja L Connor, et al.
Australian and New Zealand Journal of Medicine|October 1, 1991
Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysisD C Harris, J R Chapman, J H Stewart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2010
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patientsWajeh Y Qunibi, Carlos Martinez, Mark Smith, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2002
Contribution of anaemia to progression of renal disease: a debateJ A Rossert, W M McClellan, S D Roger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2012
Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfaSteven Fishbane, Simon D Roger, Edouard Martin, et al.
Parkinsonism & Related Disorders|May 8, 2007
The accuracy of the Unified Parkinson's Disease Rating Scale (UPDRS-Section 1) as a screening measure for depressionA McKinlay, R C Grace, J C Dalrymple-Alford, et al.
Parkinsonism & Related Disorders|July 14, 2007
A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementiaA McKinlay, R C Grace, J C Dalrymple-Alford, et al.
Nephron|January 1, 1992
Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometryS D Roger, J Piper, B Tucker, et al.
Journal Des Maladies Vasculaires|January 1, 1994
[Ehlers-Danlos type IV syndrome presenting as renovascular hypertension]F Rollé, D Roger, C Bedane, et al.
Clinical Nephrology|December 22, 2011
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind studyMarianne Haag-Weber, Kai-Uwe Eckardt, Walter H Hörl, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
European Journal of Nutrition|January 19, 2010
Competitive inhibition of carotenoid transport and tissue concentrations by high dose supplements of lutein, zeaxanthin and beta-caroteneYingming Wang, D Roger Illingworth, Sonja L Connor, et al.
Australian and New Zealand Journal of Medicine|October 1, 1991
Low dose erythropoietin in maintenance haemodialysis: improvement in quality of life and reduction in true cost of haemodialysisD C Harris, J R Chapman, J H Stewart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 9, 2010
A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patientsWajeh Y Qunibi, Carlos Martinez, Mark Smith, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 29, 2002
Contribution of anaemia to progression of renal disease: a debateJ A Rossert, W M McClellan, S D Roger, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 18, 2012
Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfaSteven Fishbane, Simon D Roger, Edouard Martin, et al.
Parkinsonism & Related Disorders|May 8, 2007
The accuracy of the Unified Parkinson's Disease Rating Scale (UPDRS-Section 1) as a screening measure for depressionA McKinlay, R C Grace, J C Dalrymple-Alford, et al.
Parkinsonism & Related Disorders|July 14, 2007
A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementiaA McKinlay, R C Grace, J C Dalrymple-Alford, et al.
Nephron|January 1, 1992
Comparison of haemostatic activity in haemodialysis and peritoneal dialysis patients with a novel technique, haemostatometryS D Roger, J Piper, B Tucker, et al.
Journal Des Maladies Vasculaires|January 1, 1994
[Ehlers-Danlos type IV syndrome presenting as renovascular hypertension]F Rollé, D Roger, C Bedane, et al.
Clinical Nephrology|December 22, 2011
Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind studyMarianne Haag-Weber, Kai-Uwe Eckardt, Walter H Hörl, et al.
Pageof 15